Gene: CLDN15
Official Full Name: claudin 15provided by HGNC
Gene Summary: This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jun 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28948 | CLDN15 Knockout cell line (HeLa) | Human | CLDN15 | 1:3~1:6 | Negative | Online Inquiry |
KO28949 | CLDN15 Knockout cell line (HCT 116) | Human | CLDN15 | 1:2~1:4 | Negative | Online Inquiry |
KO28950 | CLDN15 Knockout cell line (HEK293) | Human | CLDN15 | 1:3~1:6 | Negative | Online Inquiry |
KO28951 | CLDN15 Knockout cell line (A549) | Human | CLDN15 | 1:3~1:4 | Negative | Online Inquiry |
CLDN15 Gene Knockout Cell Lines are expertly engineered cellular models designed to study the function and mechanisms of the CLDN15 gene, which encodes the tight junction protein Claudin-15, known for its critical role in establishing and maintaining epithelial barriers. These cell lines have been developed with cutting-edge CRISPR-Cas9 technology to create stable knockout variants, allowing researchers to investigate the regulatory pathways and biological processes influenced by CLDN15 in both physiological and pathological contexts.
The primary function of CLDN15 is to facilitate intercellular adhesion and regulate ion and solute transport across epithelial tissues, particularly in the intestines and kidneys. By utilizing these knockout cell lines, researchers can elucidate the consequences of CLDN15 disruption on tight junction integrity, permeability, and cellular signaling pathways, thereby providing insights into conditions such as inflammatory bowel disease, kidney disorders, and various cancers.
The scientific importance of CLDN15 Gene Knockout Cell Lines extends into both research and clinical applications. These models serve as valuable tools for drug discovery, enabling the assessment of therapeutic interventions targeting tight junctions, as well as biomarker identification in disease states characterized by altered barrier functions. Moreover, they can enhance our understanding of epithelial pathophysiology, opening avenues for novel treatment strategies.
Distinct from traditional cell models, CLDN15 Gene Knockout Cell Lines present unique advantages, including precise gene editing, high reproducibility, and the ability to model complex biological systems without off-target effects associated with older techniques. Their specific targeting of the CLDN15 gene allows for tailored experiments that can lead to powerful insights.
For researchers and clinicians focused on epithelial biology and related diseases, these knockout cell lines are indispensable. Their application can drive innovation in treatment methodologies and clinical strategies, making them a valuable addition to any laboratory's toolkit. Our commitment to excellence in biologically relevant products is backed by years of expertise and a dedication to advancing scientific discovery, ensuring that our offerings equip users with the highest quality models for transformative research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.